Nanovaccine platforms for cancer immunotherapy from ex vivo engineering to in situ antigen capture strategies
Nanoscale · 2026
DOI: 10.1039/d6nr02315k ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale, 2026. Verfasst von Huan Liang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, College of Science, Nanjing Forestry University, Nanjing 21…. Hauptthemen laut MEDLINE: Immunotherapy, Nanovaccines, Neoplasms, Cancer Vaccines. Die Arbeit nennt 243 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
This review compares ex vivo -engineered and in situ antigen-capturing cancer nanovaccines, summarizes their design principles, immune mechanisms, translational barriers, and outlines strategies for personalized cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, College of Science, Nanjing Forestry University, Nanjing 210037, P. R. China. jieyang@njfu.edu.cn.
- School of Pharmacy, China Pharmaceutical University, Nanjing 210009, P. R. China. zwzhou@cpu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Liang, H., Hu, R., Lu, B., Zhang, J., Yang, J., & Zhou, Z. (2026). Nanovaccine platforms for cancer immunotherapy from ex vivo engineering to in situ antigen capture strategies. Nanoscale. https://doi.org/10.1039/d6nr02315k
Vancouver
Liang H, Hu R, Lu B, Zhang J, Yang J, Zhou Z. Nanovaccine platforms for cancer immunotherapy from ex vivo engineering to in situ antigen capture strategies. Nanoscale. 2026. doi:10.1039/d6nr02315k
BibTeX
@article{Liang2026,
author = {Liang, Huan and Hu, Runyu and Lu, Bingyan and Zhang, Jun and Yang, Jie and Zhou, Zhanwei},
title = {Nanovaccine platforms for cancer immunotherapy from ex vivo engineering to in situ antigen capture strategies},
journal = {Nanoscale},
year = {2026},
doi = {10.1039/d6nr02315k}
}
EUVIMED